Related Experiment Videos

A new class mutation of low density lipoprotein receptor with altered carbohydrate chains

S Shite1, T Seguchi, T Yoshida

  • 1Department of Biochemistry, Oita Medical School, Japan.

Insights

Mutant Chinese hamster cells resistant to monensin and compactin show altered low-density lipoprotein (LDL) receptor glycosylation, indicating a new class of LDL receptor defect potentially linked to hypercholesterolemia.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Genetics

Background:

  • Mutations affecting the low-density lipoprotein (LDL) receptor can lead to hypercholesterolemia.
  • Previous studies classified LDL receptor mutants into four groups (ldlA-D) based on altered receptor structure.

Purpose of the Study:

  • To characterize novel monensin-resistant (Monr-31) and compactin-resistant (MF-2) Chinese hamster cell mutants with altered LDL receptors.
  • To determine if these mutants belong to previously identified complementation groups or represent a new class.

Main Methods:

  • Generating and analyzing monensin-resistant (Monr-31) and compactin-resistant (MF-2) Chinese hamster cell mutants.
  • Investigating O-linked glycosylation of LDL receptors in these mutants.
  • Performing cell-cell hybridization experiments with known ldl mutants and the novel mutants.

Main Results:

  • Monr-31 and MF-2 cells exhibit altered O-linked sugar chains on their LDL receptors, with MF-2 showing a 5000-dalton reduction in mature receptor size due to glycosylation changes.
  • Hybridization of MF-2 and Monr-31 yielded cells with aberrant sugar chains, indicating they belong to the same complementation group.
  • Hybridization with previously classified ldl mutants (ldlA-D) resulted in wild-type LDL receptors, suggesting Monr-31 and MF-2 represent a new class of LDL receptor mutant.
  • Both mutants were confirmed to be defective in LDL internalization, leading to their classification as 'int' mutants.

Conclusions:

  • The monensin- and compactin-resistant mutants (Monr-31 and MF-2) define a new complementation group ('int' mutants) affecting LDL receptor function.
  • This discovery suggests a novel etiology for hypercholesterolemia, warranting examination of clinical cases for this specific defect.

Related Concept Videos